Stay updated on Palovarotene for MO: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.

Latest updates to the Palovarotene for MO: Efficacy & Safety Clinical Trial page
- Check3 days agoChange DetectedNo significant changes detected on the Study Details page; the content and layout remain focused on palovarotene MO trial details, eligibility criteria, interventions, and locations.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange Detected- Revision label updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check25 days agoChange DetectedThe Publications section text was updated to indicate publications are automatically filled from PubMed and may not all be about the study. The revision tag was updated from v3.2.0 to v3.3.1.SummaryDifference0.2%

- Check32 days agoChange DetectedThe government funding notice about possible delays and operating status was removed; study details and other content remain unchanged.SummaryDifference0.4%

- Check39 days agoChange DetectedAdded a new related publication entry for the MO-Ped trial: Sangiorgi L, Conrad EU, Shih F, Strahs A, Feldman DS. Palovarotene for patients with multiple hereditary exostosis: results of MO-Ped, Sci Rep. 2025;15(1):38563. PubMed-listed items are automatically generated by ClinicalTrials.gov and may not always be about the study.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page shows minor formatting tweaks and small copy edits with no changes to core study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Palovarotene for MO: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.